glp-1 gip gcg The activity of and for Type 2 Diabetes and Obesity Machine learning designs new GCGR/GLP-1R

Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes

Anti-Diabetes GLP-1s Ozempic and Mounjaro Source: IQVIA Analysis

The FDA granted traditional approval to Leqembi (lecanemab) in July 2023 after the Phase 3 CLARITYAD trial demonstrated clinically meaningful slowing of decline

The exact mechanism is not fully understood, but it may involve slowed gastric emptying and increased satiety through effects on central appetite centres in the brain

GLP-1 is a naturally occurring hormone released in your gut after you eat